Electromed, Inc. — Earnings Quality Grade B
ELMD · Healthcare
Generally healthy
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 141 days, change -15 days YoY
AR growth 5.7% vs revenue growth 17.0%
Revenue 17.0%, CFFO 25.7%. Cash follows revenue
Expense Quality
Inventory -11.1% vs COGS 8.0%. Normal
CapEx growth -22.5% vs revenue 17.0%. Normal
SG&A/Gross Profit = 78.7%, exceeds 70%
Gross margin 78.1%, change +1.8pp. Stable
Cash Flow Quality
CFFO/NI = 1.51. Profits backed by cash
FCF $0.0B, FCF/NI = 1.47
Accruals ratio = -7.2%. Low accruals
Insufficient data
Balance Sheet Health
Goodwill+Intangibles $0.0B = 3% of equity. Manageable
Insufficient data
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles surged 101% YoY
Manipulation Score
M-Score = -2.77 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor ELMD continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25